Dalphene Labs
Regulation, scope of practice, and the rulings that protect the clinic.
Compliance, page 2
1234See more →
Compliance
FDA delays US launch of Galdermas liquid neuromodulator Relfydess
Galderma Bid for US Launch of Relfydess Delayed Following FDA Rejection
Compliance
FDA issues Complete Response Letter for Galderma's liquid neuromodulator
FDA Issues Complete Response Letter for Galderma’s Ready-to-Use Liquid Neuromodulator BLA
Compliance
Regulators enforce strict divide between topical and injectable exosomes
Compliance Audit: The Strict Regulatory Divide Governing Topical vs. Injectable Exosomes
Compliance
FDA updates safety guidance for aesthetic radiofrequency devices
FDA Issues New Safety Assessment Guidance for Aesthetic RF Devices
Compliance
South Korea passes cosmetics law to boost exports and tighten oversight
South Korea Passes First Dedicated Beauty Industry Promotion Act to Boost Growth
Compliance
University of Miami launches aesthetic medicine certificate for Florida nurse practitioners
University of Miami Launches Academic Post-Graduate Certificate in Aesthetic Medicine for APRNs
Compliance
Filler death of Estée Lauder executive ruled an accident
A high-profile filler fatality, ruled an accident, that comes down to intravascular injection.
Compliance
Florida Requires Direct Physician Supervision for RN Botox Injectors
Florida Board of Nursing Reinforces On-Site Physician Rule for RN Injectors
Compliance
Tracking Pixels on Aesthetic Websites Trigger Heavy Fines Under Privacy Laws
The Pixel Problem: Advertising Triggers Health Data Obligations for Medical Aesthetic Practices
Compliance
MHRA strengthens botulinum toxin safety warnings over iatrogenic botulism risk
MHRA Toughens Safety Warnings for All Botulinum Toxin Products Due to Botulism Risk
Compliance
Ohio eases physician supervision rules for laser hair removal
Ohio Laser Hair Removal Rules Loosen with House Bill 377
Compliance
Injecting Topical Exosomes and Growth Factors Risks Severe FDA Sanctions
Editorial Warns Injecting Topical Cosmetics Like Exosomes Risks FDA Sanctions